What is the role of protein aggregation in neurodegeneration?

被引:482
作者
Ross, CA [1 ]
Poirier, MA [1 ]
机构
[1] Johns Hopkins Univ Hosp, Sch Med, Dept Psychiat, Div Neurobiol, Baltimore, MD 21287 USA
关键词
D O I
10.1038/nrm1742
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Neurodegenerative diseases typically involve deposits of inclusion bodies that contain abnormal aggregated proteins. Therefore, it has been suggested that protein aggregation is pathogenic. However, several lines of evidence indicate that inclusion bodies are not the main cause of toxicity, and probably represent a cellular protective response. Aggregation is a complex multi-step process of protein conformational change and accretion. The early species in this process might be most toxic, perhaps through the exposure of buried moieties such as main chain NH and CO groups that could serve as hydrogen bond donors or acceptors in abnormal interactions with other cellular proteins. This model implies that the pathogenesis of diverse neurodegenerative diseases arises by common mechanisms, and might yield common therapeutic targets.
引用
收藏
页码:891 / 898
页数:8
相关论文
共 90 条
[1]   Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death [J].
Arrasate, M ;
Mitra, S ;
Schweitzer, ES ;
Segal, MR ;
Finkbeiner, S .
NATURE, 2004, 431 (7010) :805-810
[2]   Huntingtin aggregation and toxicity in Huntington's disease [J].
Bates, G .
LANCET, 2003, 361 (9369) :1642-1644
[3]   Impairment of the ubiquitin-proteasome system by protein aggregation [J].
Bence, NF ;
Sampat, RM ;
Kopito, RR .
SCIENCE, 2001, 292 (5521) :1552-1555
[4]   Global impairment of the ubiquitin-proteasome system by nuclear or cytoplasmic protein aggregates precedes inclusion body formation [J].
Bennett, EJ ;
Bence, NF ;
Jayakumar, R ;
Kopito, RR .
MOLECULAR CELL, 2005, 17 (03) :351-365
[5]   Protein aggregation and the ubiquitin proteasome pathway: gaining the UPPer hand on neurodegeneration [J].
Berke, SJS ;
Paulson, HL .
CURRENT OPINION IN GENETICS & DEVELOPMENT, 2003, 13 (03) :253-261
[6]   Amyloid β-protein (Aβ) assembly:: Aβ40 and Aβ42 oligomerize through distinct pathways [J].
Bitan, G ;
Kirkitadze, MD ;
Lomakin, A ;
Vollers, SS ;
Benedek, GB ;
Teplow, DB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (01) :330-335
[7]   Neuronal dysfunction in a polyglutamine disease model occurs in the absence of ubiquitin-proteasome system impairment and inversely correlates with the degree of nuclear inclusion formation [J].
Bowman, AB ;
Yoo, SY ;
Dantuma, NP ;
Zoghbi, HY .
HUMAN MOLECULAR GENETICS, 2005, 14 (05) :679-691
[8]   Prefibrillar amyloid protein aggregates share common features of cytotoxicity [J].
Bucciantini, M ;
Calloni, G ;
Chiti, F ;
Formigli, L ;
Nosi, D ;
Dobson, CM ;
Stefani, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (30) :31374-31382
[9]   Diseases of protein conformation:: what do in vitro experiments tell us about in vivo diseases? [J].
Buxbaum, JN .
TRENDS IN BIOCHEMICAL SCIENCES, 2003, 28 (11) :585-592
[10]   Polyglutamine aggregation behavior in vitro supports a recruitment mechanism of cytotoxicity [J].
Chen, S ;
Berthelier, V ;
Yang, W ;
Wetzel, R .
JOURNAL OF MOLECULAR BIOLOGY, 2001, 311 (01) :173-182